|
Market Cap (5-Jun) $61,568,592 (1,444th) |
Close (30-Jun) $0.076 |
Volume (30-Jun) 120,981 |
Shortsold (26-May) 11,577 (0.00%) (629th) |
|
52w High $0.425 |
52w Low $0.056 |
P/E - |
EPS -0.02 |
ATX released this announcement to the ASX on 14 September 2022, 8:06. The announcement is not marked as price sensitive, and is 2 page(s) in length and 848.81kb in size.
You can view all announcements from ATX and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATX was 0.003% short sold according to ASIC data. It was ranked the 634th most shorted stock on the ASX. It is now ranked as the 629th most shorted stock on the ASX with 0.002% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from ATX | |
|---|---|
| AMP945 International Nonproprietary Name Narmafotinib | 21 June 2023, 8:34 |
| Amplia AGM to be held Thursday 24 August 2023 | 19 June 2023, 17:34 |
| Key to Corporate Governance Disclosures | 31 May 2023, 8:14 |
| AACR Conference Presentation | 14 September 2022, 8:06 |
| CEO Resignation | 12 September 2022, 9:33 |
| Notification regarding unquoted securities - ATX | 7 September 2022, 8:38 |
| Change of Director's Interest Notice - Dr. Warwick Tong | 7 September 2022, 8:12 |
You must be logged in to post a reply.
Amplia Therapeutics 